3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
8
Colorectal Neoplasms
6
Rectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Recurrence
2
Osteosarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Cholangiocarcinoma
2
Wilms Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Cancer Metastatic to Liver
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Metastatic Gastric Adenocarcinoma
1
Malignant Ascites
1
Locally Advanced Rectal Cancer
1
Hepatoblastoma
1
Gastroesophageal Junction Adenocarcinoma
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Interventions
Oxaliplatin
5
Mitomycin
4
Hyperthermic Intraperitoneal Chemotherapy
4
Fluorouracil
4
Cisplatin
4
Doxorubicin
3
Standard of Care
2
Paclitaxel
2
Leucovorin
2
Docetaxel
2
Blood Specimen Collection
2
Bevacizumab
2
sodium thiosulfate
1
relacorilant
1
liposomal doxorubicin
1
irinotecan sucrosofate
1
dehydroftorafur
1
X-Rays
1
Topotecan
1
Specimen Handling
1
Practice Guidelines as Topic
1
Platinum
1
Pancreatectomy
1
Pafolacianine
1
Observation
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Laparoscopy
1
LY-2157299
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Peritoneal Neoplasms
×
irinotecan sucrosofate
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled